To our community: Due to circumstances surrounding COVID-19, Clinical Research IO had to make the difficult decision to discontinue funding for Caretalk. We've decided to leave the website up as a resource for the community. Thank you so much to everyone who made this possible, and please enjoy!

Find Clinical Trials
for Alzheimer's Disease

  • Filter By Keyword
  • Recruiting Status
  • Location
1 - 10 >
Trial Condition Sponsor Status Start Date Location Follow
Clinical Performance of Reveal G4 Rapid HIV-1 Antibody Test for the Detection of HIV-1 Antibodies in Fingerstick and Venous Whole Blood Samples Alzheimer's Disease National Institutes of Health Enrolling Boston, MA
18d-mc-azet Alzheimer's Disease Lilly, Eli And Company Enrolling Tucson, AZ | Penticton, BC, MA
A 12-week, Multicenter, Active-treatment Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Alzheimer's Disease Otsuka America Pharmaceutical, Inc. Enrolling 10/12/2018 Houston, TX | Beaumont, TX
A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Agitation in Subjects With Dementia of the Alzheimer's Type Alzheimer's Disease Axsome Therapeutics, Inc. Enrolling 7/13/2017 Houston, TX | Avon, IN | Banning, CA
A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia Alzheimer's Disease Lilly, Eli And Company Enrolling 7/1/2016 Tucson, AZ | Penticton, BC, MA | Clinton, UT | Avon, IN | Banning, CA | Raleigh, NC
A 52-Week Open-Label Extension Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease Alzheimer's Disease Acadia Pharmaceuticals Enrolling 2/23/2017 Spokane, WA
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study of Gantenerumab in Patients With Early (Prodromal to Mild) Alzheimer's Disease Alzheimer's Disease Roche Laboratories Enrolling 8/22/2018 | Paducah, KY | Cambridge, MA | Avon, IN | Maitland, FL | Ocala, FL | Ocoee, FL | Raleigh, NC
janssendemo Alzheimer's Disease Janssen Pharmaceuticals, Inc. Enrolling Orlando, FL
Randomized, Double-blind, Placebo-controlled, Multicenter Studies to Evaluate the Safety and Efficacy of Azeliragon as a Treatment for Subjects With Mild Alzheimer's Disease and Impaired Glucose Tolerance Alzheimer's Disease vTv Therapeutics LLC Enrolling 6/27/2019 St. Louis, MO | Albuquerque, NM | Maitland, FL | Raleigh, NC | Lady Lake, FL
Expanded Access With Trappsol(R) Cyclo(TM) for an Individual Patient With Late Onset Alzheimer's Disease Alzheimer's Disease CRIO Enrolling Forest City, CA
1 - 10 >

Don't See Your
Research Study Here?
Add It To Caretalk!

Related Articles from Researchers & Patients